Weekly Signal Report — July 18, 2026

📉 34 crossed below 📈 34 recovered

This week, 34 stocks crossed below their 200-week moving average — entering what we call “deep value territory.” This is the signal our screener is built to detect: quality companies trading below a price level that has historically represented a floor over the prior four years.

Not every stock that crosses the line is a buy. Some are cheap for good reason. The 200-week moving average is a starting point for research, not a buy signal. Below, we break down each new crossing with the context you need to decide whether it’s opportunity or a warning.

On the other side, 34 stocks climbed back above the line this week — exiting deep value territory.

What is deep value territory?

The 200-week moving average represents roughly four years of price history. When a stock drops below this level, it means the current price is lower than the average investor paid over the last four years. For quality companies, these moments are rare — most stocks only cross below the 200-week line a handful of times in their history.

Our data shows that while 12-month returns from a crossing can be modest, 24-month returns are often significantly higher. The strategy requires patience. Not every crossing is a buying opportunity — some stocks are cheap because the business is deteriorating. That's why we pair the signal with quality metrics like free cash flow trends, insider buying, and return on equity.

📉 Newly Below the Line

CAMP — CAMP4 THERAPEUTICS CORPORATION

Healthcare - Biotechnology $193M
12.4% below $3.71 → 200WMA $4.24

Historical Context

This is the 6th time CAMP has crossed below its 200-week moving average.

Quality Signals

🔍 Insider Buying ⚠️ FCF Declining 🔄 Frequent Crosser — Weak Recoveries

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: CAMP has crossed below the 200-week MA 6 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full CAMP analysis →

CRSP — CRISPR Therapeutics AG

Healthcare - Gene Editing $4.7B
10% below $47.78 → 200WMA $53.07

Historical Context

This is the 14th time CRSP has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +42.2%. History favors the patient buyer here.

Quality Signals

🔍 Insider Buying

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full CRSP analysis →

BBAI — BigBear.ai Holdings Inc.

Technology - AI Software $1.4B
9% below $2.84 → 200WMA $3.12

Historical Context

This is the 6th time BBAI has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -18%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

🔄 Frequent Crosser — Weak Recoveries

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cycling pattern: BBAI has crossed below the 200-week MA 6 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full BBAI analysis →

NVAX — Novavax Inc.

Healthcare - Biotechnology N/A
8.8% below $8.21 → 200WMA $9.01

Historical Context

This is the 18th time NVAX has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -15.5%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

🔄 Frequent Crosser — Weak Recoveries

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • RSI still elevated (50): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cycling pattern: NVAX has crossed below the 200-week MA 18 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full NVAX analysis →

ASPI — ASP Isotopes Inc.

Energy - Isotope Enrichment $488M
8.6% below $3.88 → 200WMA $4.24

Historical Context

This is the second time ASPI has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +307.6%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full ASPI analysis →

TEM — Tempus AI Inc.

Healthcare - AI Diagnostics $9.4B
8.4% below $52.47 → 200WMA $57.31

Historical Context

This is the second time TEM has crossed below its 200-week moving average.

Quality Signals

⚠️ FCF Declining

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • RSI still elevated (58): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full TEM analysis →

GRAB — Grab Holdings Limited

Technology - Super App N/A
8.4% below $3.57 → 200WMA $3.90

Historical Context

This is the 5th time GRAB has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -39%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

🔄 Frequent Crosser — Weak Recoveries

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cycling pattern: GRAB has crossed below the 200-week MA 5 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full GRAB analysis →

STRA — Strategic Education, Inc.

Consumer Discretionary - Education Services $1.7B
7.1% below $76.53 → 200WMA $82.38

Historical Context

This is the 14th time STRA has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +0.5%. History favors the patient buyer here.

Quality Signals

🎯 Yartseva Multibagger 📈 FCF Growing 💰 9% FCF Yield 🔄 Frequent Crosser — Weak Recoveries

Things to Watch

  • Cycling pattern: STRA has crossed below the 200-week MA 14 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full STRA analysis →

URG — Ur-Energy Inc.

Energy - Uranium Mining $489M
6.1% below $1.23 → 200WMA $1.31

Historical Context

This is the 20th time URG has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +34.4%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining 📉 Distribution

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full URG analysis →

LTBR — Lightbridge Corporation

Energy - Nuclear Fuel Technology $239M
5.7% below $7.28 → 200WMA $7.72

Historical Context

This is the 16th time LTBR has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -19.4%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

⚠️ FCF Declining 🔄 Frequent Crosser — Weak Recoveries

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: LTBR has crossed below the 200-week MA 16 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full LTBR analysis →

AMBA — Ambarella, Inc.

Technology - Semiconductor Equipment & Materials $2.7B
5.1% below $61.84 → 200WMA $65.17

Historical Context

This is the 14th time AMBA has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +32.5%. History favors the patient buyer here.

Quality Signals

📈 FCF Growing 📉 Distribution

Things to Watch

  • RSI still elevated (54): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full AMBA analysis →

VNDA — Vanda Pharmaceuticals Inc.

Healthcare - Biotechnology $327M
4.9% below $5.44 → 200WMA $5.72

Historical Context

This is the 20th time VNDA has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -17.5%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

⚠️ FCF Declining 📉 RSI 25 (Oversold) 🔄 Frequent Crosser — Weak Recoveries

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Oversold (RSI 25): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: VNDA has crossed below the 200-week MA 20 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full VNDA analysis →

HRMY — Harmony Biosciences Holdings, Inc.

Healthcare - Biotechnology $2.0B
4.4% below $33.77 → 200WMA $35.32

Historical Context

This is the 8th time HRMY has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +20.6%. History favors the patient buyer here.

Quality Signals

🏆 Buffett Quality 🎯 Yartseva Multibagger 📈 FCF Growing 💰 7.7% FCF Yield

Things to Watch

  • RSI still elevated (64): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full HRMY analysis →

CVGI — Commercial Vehicle Group, Inc.

Consumer Cyclical - Auto Parts $154M
4% below $4.53 → 200WMA $4.72

Historical Context

This is the 28th time CVGI has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -1.7%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

🎯 Yartseva Multibagger 💰 19.6% FCF Yield ⚠️ FCF Declining 🔄 Frequent Crosser — Weak Recoveries

Things to Watch

  • RSI still elevated (57): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: CVGI has crossed below the 200-week MA 28 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full CVGI analysis →

IRTC — iRhythm Technologies, Inc.

Healthcare - Medical Devices $3.6B
4% below $110.88 → 200WMA $115.49

Historical Context

This is the 13th time IRTC has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +33%. History favors the patient buyer here.

Quality Signals

🔍 Insider Buying

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full IRTC analysis →

SARO — StandardAero, Inc.

Industrials - Aerospace MRO $8.9B
3.9% below $26.73 → 200WMA $27.82

Historical Context

This is the 4th time SARO has crossed below its 200-week moving average.

Quality Signals

🔍 Insider Buying ⚠️ FCF Declining 🔄 Frequent Crosser — Weak Recoveries

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: SARO has crossed below the 200-week MA 4 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full SARO analysis →

BIDU — Baidu Inc.

Communication Services - Internet $36.5B
3.7% below $107.24 → 200WMA $111.39

Historical Context

This is the 19th time BIDU has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +37.3%. History favors the patient buyer here.

Quality Signals

💰 21.8% FCF Yield ⚠️ FCF Declining

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full BIDU analysis →

LOPE — Grand Canyon Education, Inc.

Consumer Defensive - Education & Training Services $3.7B
3.4% below $140.44 → 200WMA $145.40

Historical Context

This is the 16th time LOPE has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +15.4%. History favors the patient buyer here.

Quality Signals

🏆 Buffett Quality 📈 FCF Growing 💰 6.1% FCF Yield

Things to Watch

  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full LOPE analysis →

CI — The Cigna Group

Healthcare - Insurance $74.5B
3.3% below $281.45 → 200WMA $290.98

Historical Context

This is the 24th time CI has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +12.7%. History favors the patient buyer here.

Quality Signals

💰 9.3% FCF Yield

Things to Watch

  • RSI still elevated (56): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full CI analysis →

BTU — Peabody Energy Corporation

Energy - Thermal Coal $2.7B
3.1% below $22.44 → 200WMA $23.16

Historical Context

This is the 5th time BTU has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -37.2%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

⚠️ FCF Declining 🔄 Frequent Crosser — Weak Recoveries

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: BTU has crossed below the 200-week MA 5 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full BTU analysis →

BEAM — Beam Therapeutics Inc.

Healthcare - Biotechnology $2.8B
2.7% below $27.53 → 200WMA $28.29

Historical Context

This is the 6th time BEAM has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -41.5%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

⚠️ FCF Declining 🔄 Frequent Crosser — Weak Recoveries

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • RSI still elevated (50): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: BEAM has crossed below the 200-week MA 6 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full BEAM analysis →

NFLX — Netflix Inc.

Communication Services - Streaming $290.3B
2.5% below $68.95 → 200WMA $70.74

Historical Context

This is the 14th time NFLX has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +41.9%. History favors the patient buyer here.

Quality Signals

🏆 Buffett Quality 📈 FCF Growing 💰 8.8% FCF Yield 📉 RSI 12 (Oversold) 💥 Capitulation Volume

Things to Watch

  • Oversold (RSI 12): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full NFLX analysis →

NG — NovaGold Resources Inc.

Basic Materials - Gold $2.3B
2.1% below $5.18 → 200WMA $5.29

Historical Context

This is the 13th time NG has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -8%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

⚠️ FCF Declining 🔄 Frequent Crosser — Weak Recoveries

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: NG has crossed below the 200-week MA 13 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full NG analysis →

BTDR — Bitdeer Technologies Group

Technology - Bitcoin Mining $2.6B
1.8% below $10.74 → 200WMA $10.94

Historical Context

This is the 9th time BTDR has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +38.6%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full BTDR analysis →

ALK — Alaska Air Group, Inc.

Industrials - Airlines $5.1B
1.8% below $45.51 → 200WMA $46.34

Historical Context

This is the 33th time ALK has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +16.1%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • RSI still elevated (56): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full ALK analysis →

JBSS — John B. Sanfilippo & Son, Inc.

Consumer Defensive - Packaged Foods $929M
1.6% below $79.47 → 200WMA $80.77

Historical Context

This is the 16th time JBSS has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -16.5%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

🏆 Buffett Quality ⚠️ FCF Declining 🔄 Frequent Crosser — Weak Recoveries

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: JBSS has crossed below the 200-week MA 16 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full JBSS analysis →

KVUE — Kenvue Inc.

Consumer Staples - Personal Care $36.4B
1.4% below $18.98 → 200WMA $19.25

Historical Context

This is the 5th time KVUE has crossed below its 200-week moving average.

Quality Signals

👑 Dividend Aristocrat 🔍 Insider Buying 💰 5.1% FCF Yield 🔄 Frequent Crosser — Weak Recoveries

Things to Watch

  • RSI still elevated (68): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cycling pattern: KVUE has crossed below the 200-week MA 5 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full KVUE analysis →

ONON — On Holding AG

Consumer Discretionary - Athletic Footwear $12.4B
1.1% below $37.20 → 200WMA $37.63

Historical Context

This is the 5th time ONON has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +71.8%. History favors the patient buyer here.

Quality Signals

🏆 Buffett Quality 🔍 Insider Buying

Things to Watch

  • RSI still elevated (58): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full ONON analysis →

PCVX — Vaxcyte Inc.

Healthcare - Biotechnology $8.1B
1.1% below $56.20 → 200WMA $56.86

Historical Context

This is the 5th time PCVX has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +59.4%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full PCVX analysis →

EPAC — Enerpac Tool Group Corp.

Industrials - Specialty Industrial Machinery $1.8B
1% below $34.61 → 200WMA $34.95

Historical Context

This is the 20th time EPAC has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +3.2%. History favors the patient buyer here.

Quality Signals

🏆 Buffett Quality 📈 FCF Growing 💰 5.8% FCF Yield 🔄 Frequent Crosser — Weak Recoveries

Things to Watch

  • Cycling pattern: EPAC has crossed below the 200-week MA 20 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full EPAC analysis →

HLF — Herbalife Ltd.

Consumer Defensive - Packaged Foods $1.2B
0.6% below $11.99 → 200WMA $12.06

Historical Context

This is the 18th time HLF has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +34.5%. History favors the patient buyer here.

Quality Signals

📈 FCF Growing 💰 28.1% FCF Yield

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full HLF analysis →

MTLS — Materialise NV

Technology - Software - Application $379M
0.6% below $6.54 → 200WMA $6.58

Historical Context

This is the 8th time MTLS has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +10.7%. History favors the patient buyer here.

Quality Signals

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • RSI still elevated (69): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full MTLS analysis →

SYK — Stryker Corporation

Healthcare - Medical Devices $122.6B
0.4% below $319.87 → 200WMA $321.23

Historical Context

This is the 23th time SYK has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +41.8%. History favors the patient buyer here.

Quality Signals

📈 FCF Growing

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full SYK analysis →

EXP — Eagle Materials Inc.

Basic Materials - Building Materials $6.4B
0.1% below $205.93 → 200WMA $206.19

Historical Context

This is the 23th time EXP has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +14.8%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • RSI still elevated (53): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full EXP analysis →

📈 Recovered Above the Line

These stocks climbed back above their 200-week moving average this week. If you bought during their time below the line, this is a milestone — though not necessarily a sell signal.

AQN
Algonquin Power & Utilities Corp.
0% above · $5.84
RLI
RLI Corp.
0.1% above · $61.57
SNY
Sanofi
0.2% above · $44.66
PII
Polaris Inc.
0.4% above · $73.20
MATW
Matthews International Corporation
0.5% above · $27.46
STE
Steris plc
0.6% above · $217.84
NBR
Nabors Industries Ltd.
0.9% above · $83.89
BALY
Bally's Corporation
1.1% above · $14.06
PG
The Procter & Gamble Company
1.3% above · $149.98
LE
Lands' End, Inc.
1.4% above · $11.60
INVH
Invitation Homes Inc.
1.5% above · $30.12
AVNT
Avient Corporation
1.6% above · $36.97
AORT
Artivion, Inc.
1.7% above · $25.06
ICE
Intercontinental Exchange Inc.
2.1% above · $139.65
GPI
Group 1 Automotive, Inc.
2.1% above · $326.06
GPRE
Green Plains Inc.
2.4% above · $19.23
CRGY
Crescent Energy Company
2.6% above · $10.75
DEA
Easterly Government Properties, Inc.
2.7% above · $25.56
HURN
Huron Consulting Group Inc.
2.7% above · $114.80
ARES
Ares Management Corporation
2.7% above · $125.68
OXY
Occidental Petroleum Corporation
2.9% above · $54.86
HLI
Houlihan Lokey, Inc.
3% above · $140.01
FG
F&G Annuities & Life, Inc.
3.2% above · $32.10
S
SentinelOne Inc.
3.3% above · $19.57
MTDR
Matador Resources Company
3.7% above · $53.80
ADP
Automatic Data Processing, Inc.
4.8% above · $255.26
BOX
Box Inc.
5.3% above · $30.48
GXO
GXO Logistics, Inc.
5.5% above · $54.05
YMM
Full Truck Alliance Co. Ltd.
6% above · $9.14
LCII
LCI Industries
6% above · $108.17
CHRD
Chord Energy Corporation
6.3% above · $128.10
PTEN
Patterson-UTI Energy, Inc.
6.6% above · $10.02
GEVO
Gevo, Inc.
7% above · $1.63
EVCM
EverCommerce Inc.
16.7% above · $12.04

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.